BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 34157302)

  • 1. Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop.
    Marangoni F; Zhakyp A; Corsini M; Geels SN; Carrizosa E; Thelen M; Mani V; Prüßmann JN; Warner RD; Ozga AJ; Di Pilato M; Othy S; Mempel TR
    Cell; 2021 Jul; 184(15):3998-4015.e19. PubMed ID: 34157302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression.
    Yamaguchi T; Kishi A; Osaki M; Morikawa H; Prieto-Martin P; Wing K; Saito T; Sakaguchi S
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):E2116-25. PubMed ID: 23690575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
    Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
    Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
    PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis.
    Holt MP; Punkosdy GA; Glass DD; Shevach EM
    J Immunol; 2017 Feb; 198(4):1503-1511. PubMed ID: 28053234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells.
    Ovcinnikovs V; Ross EM; Petersone L; Edner NM; Heuts F; Ntavli E; Kogimtzis A; Kennedy A; Wang CJ; Bennett CL; Sansom DM; Walker LSK
    Sci Immunol; 2019 May; 4(35):. PubMed ID: 31152091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
    Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
    Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.
    Onishi Y; Fehervari Z; Yamaguchi T; Sakaguchi S
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10113-8. PubMed ID: 18635688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.
    Lu Y; Schneider H; Rudd CE
    Blood; 2012 Nov; 120(23):4560-70. PubMed ID: 23047820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.
    Hiura T; Kagamu H; Miura S; Ishida A; Tanaka H; Tanaka J; Gejyo F; Yoshizawa H
    J Immunol; 2005 Oct; 175(8):5058-66. PubMed ID: 16210609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated CTLA-4-independent immunosuppression of Treg cells disturbs CTLA-4 blockade-mediated antitumor immunity.
    Watanabe T; Ishino T; Ueda Y; Nagasaki J; Sadahira T; Dansako H; Araki M; Togashi Y
    Cancer Sci; 2023 May; 114(5):1859-1870. PubMed ID: 36762794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement.
    Wang CJ; Heuts F; Ovcinnikovs V; Wardzinski L; Bowers C; Schmidt EM; Kogimtzis A; Kenefeck R; Sansom DM; Walker LS
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):524-9. PubMed ID: 25548162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation.
    Panda AK; Kim YH; Shevach EM
    J Immunol; 2022 Feb; 208(4):851-860. PubMed ID: 35039334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Tolerance-Promoting Function of Regulatory T Cells Is Optimized by CD28, but Strictly Dependent on Calcineurin.
    Marangoni F; Zhang R; Mani V; Thelen M; Ali Akbar NJ; Warner RD; Äijö T; Zappulli V; Martinez GJ; Turka LA; Mempel TR
    J Immunol; 2018 May; 200(10):3647-3661. PubMed ID: 29661826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
    Ohue Y; Nishikawa H
    Cancer Sci; 2019 Jul; 110(7):2080-2089. PubMed ID: 31102428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.
    Lozano T; Villanueva L; Durántez M; Gorraiz M; Ruiz M; Belsúe V; Riezu-Boj JI; Hervás-Stubbs S; Oyarzábal J; Bandukwala H; Lourenço AR; Coffer PJ; Sarobe P; Prieto J; Casares N; Lasarte JJ
    J Immunol; 2015 Oct; 195(7):3180-9. PubMed ID: 26324768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8
    Semmrich M; Marchand JB; Fend L; Rehn M; Remy C; Holmkvist P; Silvestre N; Svensson C; Kleinpeter P; Deforges J; Junghus F; Cleary KL; Bodén M; Mårtensson L; Foloppe J; Teige I; Quéméneur E; Frendéus B
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35058324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory Rebound in IL-12-Treated Tumors Is Driven by Uncommitted Peripheral Regulatory T Cells.
    Li Q; Virtuoso LP; Anderson CD; Egilmez NK
    J Immunol; 2015 Aug; 195(3):1293-300. PubMed ID: 26085681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quorum Regulation via Nested Antagonistic Feedback Circuits Mediated by the Receptors CD28 and CTLA-4 Confers Robustness to T Cell Population Dynamics.
    Zenke S; Palm MM; Braun J; Gavrilov A; Meiser P; Böttcher JP; Beyersdorf N; Ehl S; Gerard A; Lämmermann T; Schumacher TN; Beltman JB; Rohr JC
    Immunity; 2020 Feb; 52(2):313-327.e7. PubMed ID: 32049052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody.
    Ha D; Tanaka A; Kibayashi T; Tanemura A; Sugiyama D; Wing JB; Lim EL; Teng KWW; Adeegbe D; Newell EW; Katayama I; Nishikawa H; Sakaguchi S
    Proc Natl Acad Sci U S A; 2019 Jan; 116(2):609-618. PubMed ID: 30587582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.